Document Detail

Renal angiomyolipoma with coexistent hemorrhagic aneurysm formation and fatty thrombus in inferior vena cava: a rare presentation.
MedLine Citation:
PMID:  22450723     Owner:  NLM     Status:  Publisher    
Angiomyolipoma (AML) is known as the most common benign mesenchymal tumor of kidney. Usually AMLs present as benign lesions without local invasion or complication. However, few cases of renal AML have been reported with complications such as tumor thrombus extension into inferior vena cava (IVC) or hemorrhagic aneurysm formation. We report a complicated case of renal AML with CT and angiography evidence of hemorrhagic aneurysm formation and IVC thrombus, treated by a combination of selective arterial embolization, radical nephrectomy and thrombectomy. Radiologists and clinicians should be aware that AMLs could have such aggressive behaviors.
Hao-Ming Li; Lee-Ren Yeh; Kevin Lu
Related Documents :
22706743 - Portal vein embolization with different embolic agents for right hepatectomy.
22654253 - Acute thrombosis of left portal vein during right portal vein embolization extended to ...
18336903 - Characterisation of tone oscillations in placental and myometrial arteries from normal ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-28
Journal Detail:
Title:  Abdominal imaging     Volume:  -     ISSN:  1432-0509     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-3-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9303672     Medline TA:  Abdom Imaging     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Radiology, E-Da Hospital, No. 1, Yida Road, Yanchao District, Kaohsiung City, 82445, Taiwan,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Elements of 'missing heritability'
Next Document:  Patient-controlled sedation for ERCP: a randomized double-blind comparison of alfentanil and remifen...